Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice

Biomaterials

Volumn 31, Issue 4, 2010, Pages 594-601

  Rogers, Todd H ^a   Babensee, Julia E ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Acute inflammation; Biomaterials; Host response; Toll like receptors

Indexed keywords

BODY FLUIDS; INTERFERONS; MAMMALS; PATTERN RECOGNITION;

ACUTE INFLAMMATION; BIOMATERIAL SURFACES; CHRONIC INFLAMMATORY; HOST RESPONSE; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; PATTERN RECOGNITION RECEPTORS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BIOMATERIALS;

BIOMATERIAL; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC DISEASE; CONTROLLED STUDY; IMPLANT; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MICROCAPSULE; MONOCYTE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; SURFACE PROPERTY; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MOUSE MUTANT; MUSCLE; SKIN;

MUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MONOCYTES; MUSCLES; NEUTROPHILS; SKIN; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75549085097     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.09.077     Document Type: Article

References (49)

1. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008;20:86-100.
2. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005;11:1-18.
3. McNally AK, Anderson JM. Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci U S A 1994;91:10119-23.
4. Brodbeck WG, Colton E, Anderson JM. Effects of adsorbed heat labile serum proteins and fibrinogen on adhesion and apoptosis of monocytes/macrophages on biomaterials. J Mater Sci Mater Med 2003;14:671-5.
5. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004;25:5681-703.
6. Tang L,Wu Y, Timmons RB. Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces. J Biomed Mater Res 1998;42:156-63.
7. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993;178:2147-56.
8. Hu WJ, Eaton JW, Ugarova TP, Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001;98:1231-8.
9. McNally AK, Anderson JM. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 2002;160:621-30.
10. Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996;97:1329-34.
11. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
12. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5.
13. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5:1249-55.
14. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008;3:99-126.
15. Akira S, Uematsu S, Takeuchi O. Pathogen reconition and innate immunity. Cell 2006;124:783-801.
16. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
17. Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003;170:5268-75.
18. Levy R, Prince J, Yang R, Mollen K, Liao H, Watson G, et al. Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am J Physiol Regul Integr Comp Physiol 2006;291:R970-6.
19. Bettinger D, Pellicane J, Tarry W, Yager D, Diegelmann R, Lee R, et al. The role of inflammatory cytokines in wound healing: accelerated healing in endotoxinresistant mice. J Trauma 1994;36:810-4.
20. Barsness K, Arcaroli J, Harken A, Abraham E, Banerjee A, Reznikov L, et al. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 2004;281:R592-9.
21. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005;11:1173-9.
22. Mollen K, Anand R, Tsung A, Prince J, Levy R, Billiar T. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006;26:430-7.
23. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006;116:2262-71.
24. Anderson JM. Biological responses to materials. Annu Rev Mater Res 2001;31:81-110.
25. Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, et al. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8 + T cell-mediated anti-tumor immunity. Vaccine 2008;26:5046-57.
26. Schlosser E, Mueller M, Fischer S, Basta S, Busch DH, Gander B, et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008;26:1626-37.
27. Matzelle M, Babensee J. Humoral immune responses to model antigen codelivered with biomaterials used in tissue engineering. Biomaterials 2004;25:295-304.
28. Babensee JE. Interaction of dendritic cells with biomaterials. Semin Immunol 2008;20:101-8.
29. Bennewitz N, Babensee J. The effect of the physical form of poly(lactic-coglycolic acid) carriers on the humoral immune response to co-delivered antigens. Biomaterials 2005;26:2991-9.
30. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 2009;106:870-5.
31. Iwamoto M, Kurachi M, Nakashima T, Kim D, Yamaguchi K, Oda T, et al. Structure-activity relationship of alginate oligosaccharides in the induction of cytokine production from RAW264.7 cells. FEBS Lett 2005;579:4423-9.
32. Grandjean-Laquerriere A, Tabary O, Jacquot J, Richard D, Frayssinet P, Guenounou M, et al. Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials 2007;28:400-4.
33. Poltorak A, He X, Smirnova I, Liu M, Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8.
34. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
35. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003;171:1473-83.
36. Tang L, Jiang W, Welty SE. The participation of P-and E-selectins on biomaterial-mediated tissue responses. J Biomed Mater Res 2002;62:471-7.
37. Busuttil SJ, Ploplis VA, Castellino FJ, Tang L, Eaton JW, Plow EF. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost 2004;2:1798-805.
38. Keselowsky B, Bridges A, Burns K, Tate C, Babensee J, LaPlaca M, et al. Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 2007;28:3626-31.
39. Zdolsek J, Eaton J, Tang L. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 2007;5:31.
40. Yu M, Wang H, Ding A, Golenbock D, Latz E, Czura C, et al. HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 2006;26:174-9.
41. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004;76:514-9.
42. Maitra R, Clement CC, Crisi GM, Cobelli N, Santambrogio L. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation. PLoS ONE 2008;3:e2438.
43. Chen C, Kono H, Golenbock D, Reed G, Akira S, Rock K. Identifcation of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007;13:851-6.
44. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 1999;163:5029-38.
45. Ward J, Dower S, Whyte M, Buttle D, Sabroe I. Potentiation of TLR4 signaling by plasmin activity. Biochem Biophys Res Commun 2006;341:299-303.
46. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-33.
47. Monick MM, Powers L, Butler N, Yarovinsky T, Hunninghake GW. Interaction of matrix with integrin receptors is required for optimal LPS-induced MAP kinase activation. Am J Physiol Lung Cell Mol Physiol 2002;283:L390-402.
48. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-84.
49. Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol 2007;178:5271-6.